Besides, IL-6 promotes the proliferation of haematological malignancies (leukemia, lymphoma and myeloma), and solid tumours (breast and renal adenocarcinoma or Kaposi sarcoma) [1], [2], through an intracrine, autocrine and paracrine mode of action [3], [4]. This evidence concerns the gene IL6 and leukemia.